Stay updated on Upadacitinib vs Methotrexate in RA Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Methotrexate in RA Clinical Trial page.

Latest updates to the Upadacitinib vs Methotrexate in RA Clinical Trial page
- CheckyesterdayChange DetectedRheumatoid arthritis and MedlinePlus Genetics are now listed under Related topics, providing quick access to background information and related resources on the page. This update expands contextual links to help users explore related conditions and genetics topics relevant to the study.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA minor ClinicalTrials.gov interface revision is reflected on the page. Any accompanying removal of a generic “related topics”/previous revision reference does not affect the study’s clinical information.SummaryDifference0.1%

- Check23 days agoChange DetectedRheumatoid arthritis is added as a topic and a related topic link to MedlinePlus Genetics appears; the page revision is updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page no longer includes rheumatoid arthritis, related topics, or MedlinePlus Genetics sections.SummaryDifference0.1%

- Check51 days agoChange DetectedAdded related topics including Rheumatoid arthritis and MedlinePlus Genetics, and updated the revision to v3.5.0. Deleted the previous revision note v3.4.3.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.4.3 updated from v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib vs Methotrexate in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Methotrexate in RA Clinical Trial page.